Teva Turnaround Hung Up By The Uncertain Cost Of Settling Opioid Cases

SC1911_U-Turn_763128463_1200.jpg
Teva's effort to turn the business around faces a big obstacle • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Earnings

More from Business